23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Defensin Production by Human Limbo-Corneal Fibroblasts Infected with Mycobacteria

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Epithelial cells of the cornea and the conjunctiva constitutively produce antimicrobial peptides; however, the production of defensins by other cell types located around the eye has not been investigated. We analyzed the production of beta-defensins (hBD) and cathelicidin LL-37 during the infection of primary limbo-corneal fibroblasts with M. tuberculosis (MTB), M. abscessus (MAB), and M. smegmatis (MSM). The intracellular survival of each mycobacterium, the production of cytokines and the changes on the distribution of the actin filaments during the infection were also analyzed. Fibroblasts produce basal levels of hBD1 and LL-37 and under PMA stimulation they produce hBD2, hBD3 and overexpress hBD1 and LL-37. MAB induced the highest levels of hBD1 and LL-37 and intermediate levels of IL-6; however, MAB was not eliminated. In addition, MAB induced the greatest change to the distribution of the actin filaments. MTB also produced changes in the structure of the cytoskeleton and induced low levels of hBD1 and IL-6, and intermediate levels of LL-37. The balance of these molecules induced by MTB appeared to contribute to the non-replicative state observed in the limbo-corneal cells. MSM induced the lowest levels of hBD1 and LL-37 but the highest levels of IL-6; MSM was eliminated. The results suggest that mycobacterial infections regulate the production of antimicrobial peptides and cytokines, which in conjunction can contribute to the control of the bacilli.

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: not found

          Resolution of inflammation: state of the art, definitions and terms.

          A recent focus meeting on Controlling Acute Inflammation was held in London, April 27-28, 2006, organized by D.W. Gilroy and S.D. Brain for the British Pharmacology Society. We concluded at the meeting that a consensus report was needed that addresses the rapid progress in this emerging field and details how the specific study of resolution of acute inflammation provides leads for novel anti-inflammatory therapeutics, as well as defines the terms and key components of interest in the resolution process within tissues as appreciated today. The inflammatory response protects the body against infection and injury but can itself become dysregulated with deleterious consequences to the host. It is now evident that endogenous biochemical pathways activated during defense reactions can counter-regulate inflammation and promote resolution. Hence, resolution is an active rather than a passive process, as once believed, which now promises novel approaches for the treatment of inflammation-associated diseases based on endogenous agonists of resolution.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            A peptide antibiotic from human skin.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Intraocular tuberculosis--an update.

              The lack of any uniform diagnostic criteria for intraocular tuberculosis, in either immunocompetent or immunocompromised individuals, has contributed to the confusion regarding diagnosis and management. However, recent studies addressing the clinical significance of purified protein derivative test results, computerized tomography of the chest, and molecular diagnostic procedures have provided a new approach to establishing the diagnosis of ocular tuberculosis. The current review focuses on the diagnostic modalities used for the clinical management of intraocular tuberculosis, with the emphasis on diagnostic criteria, various clinical features, and treatments recommended in recent publications. Furthermore, the current review addresses the diagnostic criteria for intraocular tuberculosis, the spectrum of tuberculosis in patients with AIDS and in those on anti-tumor necrosis factor agents, and management of drug-resistant tuberculosis.
                Bookmark

                Author and article information

                Journal
                Pathogens
                Pathogens
                pathogens
                Pathogens
                MDPI
                2076-0817
                04 February 2013
                March 2013
                : 2
                : 1
                : 13-32
                Affiliations
                [1 ]Department of Immunology, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N, 11340 México, D.F., Mexico; E-Mails: jordyfilm@ 123456yahoo.com.mx (J.I.C.S.); abrilestela@ 123456hotmail.com (B.E.G.P.); ana_rosa_duarte@ 123456hotmail.com (A.R.M.D.); shantal_baliz@ 123456hotmail.com (S.L.B.U.); julietalunah@ 123456hotmail.com (J.L.H.)
                [2 ]Research Unit, Instituto de Oftalmología Conde de Valenciana, Chimalpopoca 14 Colonia Obrera, 06800 México DF, Mexico; E-Mails: mejialopezh@ 123456yahoo.com.mx (H.M.L.); clo2r@ 123456yahoo.com.mx (C.L.L.); vbautistal@ 123456institutodeoftalmologia.org (V.M.B.D.L.)
                [3 ]Biomedical Research Center, Hospital Nuestra Señora de la Luz, IAP. Ezequiel Montes 135, 06030 México DF, Mexico; E-Mail: atzinrc@ 123456gmail.com
                Author notes
                [* ]Author to whom correspondence should be addressed; E-Mail: julietalunah@ 123456hotmail.com ; Tel.: +52-55-57296300 (ext. 62371); Fax: +52-55-57296300 (ext. 62371).
                Article
                pathogens-02-00013
                10.3390/pathogens2010013
                4235707
                25436879
                ca98117a-b178-4976-ab13-9f19019f19ec
                © 2013 by the authors; licensee MDPI, Basel, Switzerland.

                This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license ( http://creativecommons.org/licenses/by/3.0/).

                History
                : 09 December 2012
                : 24 December 2012
                : 24 January 2013
                Categories
                Article

                human beta-defensin,cathelicidin ll-37,fibroblasts,limbo-corneal cells,mycobacterium abscessus,mycobacterium tuberculosis,mycobacterium smegmatis,fibroblast cytoskeleton,il-6

                Comments

                Comment on this article